These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25063700)

  • 1. [Importance of the interdisciplinary, evidence-based diagnosis of polycystic ovary syndrome].
    Gődény S; Csenteri O
    Orv Hetil; 2014 Jul; 155(30):1175-88. PubMed ID: 25063700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evidence-based therapy of polycystic ovarian syndrome].
    Gődény S; Csenteri OK
    Orv Hetil; 2015 Nov; 156(45):1803-15. PubMed ID: 26551444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention and treatment of the complications of polycystic ovarian syndrome--the significance of evidence-based, interdisciplinary management].
    Gődény S; Csenteri OK
    Orv Hetil; 2015 Dec; 156(50):2018-26. PubMed ID: 26639643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls].
    Ságodi L; Barkai L
    Orv Hetil; 2013 Jan; 154(4):136-42. PubMed ID: 23335723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis.
    Christ JP; Gunning MN; Fauser BCJM
    Reprod Biomed Online; 2017 Oct; 35(4):480-483. PubMed ID: 28733169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome.
    Lentscher JA; Decherney AH
    Clin Obstet Gynecol; 2021 Mar; 64(1):3-11. PubMed ID: 32701517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
    Housman E; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Treatment of Polycystic Ovary Syndrome.
    Williams T; Mortada R; Porter S
    Am Fam Physician; 2016 Jul; 94(2):106-13. PubMed ID: 27419327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-Based Management of Infertility in Women With Polycystic Ovary Syndrome.
    Bergh CM; Moore M; Gundell C
    J Obstet Gynecol Neonatal Nurs; 2016; 45(1):111-22. PubMed ID: 26815805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polycystic ovary syndrome I. Clinical presentation and treatment].
    Ovesen PG; Møller N; Greisen S; Ingerslev HJ
    Ugeskr Laeger; 1998 Jan; 160(3):260-4. PubMed ID: 9454393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E; Azziz R
    Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
    Szpringer EA; Lutnicki KR; Zych IS
    Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome.
    Yao LQ; Kuang JQ; Feng YJ; Yang DZ; Li L; Xu CJ
    Fertil Steril; 2006 Mar; 85(3):805-8. PubMed ID: 16500371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic consequences of polycystic ovary syndrome.
    Churchill SJ; Wang ET; Pisarska MD
    Minerva Ginecol; 2015 Dec; 67(6):545-55. PubMed ID: 26372304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychosocial approach in polycystic ovary syndrome].
    Kohlné Papp I
    Orv Hetil; 2014 Nov; 155(47):1867-71. PubMed ID: 25403280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.